Who is sponsoring NCT03134001?

NCT03134001 is sponsored by Dosentrx Ltd..

What drugs are being tested in NCT03134001?

Interventions in NCT03134001: patients receiving oral analgesics via the PCoA™ Acute.

What condition does NCT03134001 study?

NCT03134001 studies Pain, Postoperative.

Is NCT03134001 still recruiting?

NCT03134001 is currently completed. Last updated 8 May 2017.

Last reviewed 2017-05-08 · How we verify

NCT03134001

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Oral PCA Device - PCoA™ Acute

Completed NA Last updated 8 May 2017

What this trial tests

NA trial testing patients receiving oral analgesics via the PCoA™ Acute in Pain, Postoperative in 70 participants. Completed in 30 November 2015.

Timeline

1 June 2015

Primary endpoint
30 November 2015

30 November 2015

Quick facts

Lead sponsor	Dosentrx Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	1 June 2015
Primary completion	30 November 2015
Estimated completion	30 November 2015

Drugs / interventions tested

patients receiving oral analgesics via the PCoA™ Acute

Conditions studied

Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

Dosentrx Ltd.

Who can join

Adults 18 to 80, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, open label, controlled pilot clinical study comprised hospitalized post operative patients receiving oral analgesics. The study aims to evaluate the safety, efficacy and usability of a novel pill dispensing system - PCoA™ Acute and compare it to the conventional procedure of nurse providing analgesics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the <i>PCoA® Acute</i> Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study.
Wirz S, Conrad S, Shtrichman R, Schimo K, et al · · 2017 · cited 5× · PMID 29093632 · DOI 10.1155/2017/7962135

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting

Other Dosentrx Ltd. trials

Trials by the same sponsor.

NCT06344416 — Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Out · NA · recruiting
NCT06335758 — Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication. · unknown
NCT04215796 — Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF). · NA · unknown
NCT03424330 — Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03134001 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dosentrx Ltd.
Last refreshed: 8 May 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03134001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing